| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | linaclotide | FAERS: 2 | US FAERS | |
| 2 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 3 | Deferasirox | FAERS: 1 | US FAERS | |
| 4 | Diltiazem | FAERS: 1 | US FAERS | |
| 5 | Ethylene Glycol | FAERS: 1 | US FAERS | |
| 6 | Finasteride | FAERS: 1 | US FAERS | |
| 7 | Lenalidomide | FAERS: 1 | US FAERS | |
| 8 | Loperamide | FAERS: 1 | US FAERS | |
| 9 | Sorafenib | FAERS: 1 | US FAERS | |
| 10 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 11 | ziconotide | FAERS: 1 | US FAERS | |
| 12 | Lasofoxifene | SIDER | ||
| 13 | Lisdexamfetamine Dimesylate | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Paroxetine | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.